Brind.

BMD is listed on Nasdaq and received positive feedback from the FDA regarding its Phase 3 drug protocol.

2 reports, 2 independent Updated Sat 00:00

No new developments lately

Reports: 2
Developments: 2
Repetition: 0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

BMD is listed on Nasdaq and received positive feedback from the FDA regarding its Phase 3 drug protocol.

Who's involved

What this event is mainly about

BMD FDA

How it developed

Newest first. Tap a step to see who reported it.

Sat 00:00BMD announced a new bone health initiative partnership with OSI.1 source
- freepressjournal.in
Jun 22BMD, listed on Nasdaq, gets positive FDA feedback on Phase 3 protocol.1 source
- manilatimes.net

Keep exploring

The entities involved

BMD
company

Nothing else this week.
FDA
- The FDA granted Orphan Drug Designation to sovleplenib, a drug associated with HUTCHMED, which operates in China.03:27
- Mesoblast is seeking FDA review of the BLA for its product rexlemestrocel-L.03:21

Coverage

Newest first; wire copies grouped

Sat 00:00freepressjournal.in
Jun 22manilatimes.net